EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Anticoagulant therapy in COVID ‐19: A narrative review

Zeinab Mohseni Afshar iD, Ali Tavakoli Pirzaman iD, Rezvan Hosseinzadeh iD, Arefeh Babazadeh iD, Mohamad Ali Taghizadeh Moghadam, Seyed Rouhollah Miri iD, Terence T Sio iD, Mark J M Sullman iD, Mohammad Barary iD, Soheil Ebrahimpour iD

Clinical and Translational Science · 2023

DOI: 10.1111/cts.13569 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Translational Science, 2023. Verfasst von Zeinab Mohseni Afshar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran. Hauptthemen laut MEDLINE: COVID-19, Blood Coagulation Disorders, Thrombosis. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronavirus disease 2019 (COVID‐19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), can manifest itself in several ways, including coagulopathy and thrombosis. These complications can be the first and sometimes only manifestations of SARS‐CoV‐2 infection and can occur early or late in the course of the disease. However, these symptoms are more prevalent in hospitalized patients with venous thromboembolism, particularly those admitted to intensive care units. Moreover, various forms of arterial and venous thrombosis, or micro‐ or macro‐vasculature embolisms, have been reported during the current pandemic. They have led to harmful consequences, such as neurological and cardiac events, nearly all resulting from the hypercoagulable state caused by this viral infection. The severe hypercoagulability observed in patients with COVID‐19 accounts for most cases of the disease that become critical. Therefore, anticoagulants seem to be one of the most vital therapeutics for treating this potentially life‐threatening condition. In the current paper, we present a thorough review of the pathophysiology of COVID‐19‐induced hypercoagulable state and the use of anticoagulants to treat SARS‐CoV‐2 infections in different patient groups, as well as their pros and cons.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Blood Coagulation DisordersThrombosisHumansSARS-CoV-2Anticoagulants

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
  • Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
  • Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Science, Tehran, Iran.
  • Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA.

ORCID-Profile: Zeinab Mohseni Afshar, Ali Tavakoli Pirzaman, Rezvan Hosseinzadeh, Arefeh Babazadeh, Seyed Rouhollah Miri, Terence T Sio, Mark J M Sullman, Mohammad Barary, Soheil Ebrahimpour

Zitieren

APA

Mohseni Afshar, Z., Tavakoli Pirzaman, A., Hosseinzadeh, R., Babazadeh, A., Taghizadeh Moghadam, M. A., Miri, S. R., Sio, T. T., Sullman, M. J. M., Barary, M., & Ebrahimpour, S. (2023). Anticoagulant therapy in COVID ‐19: A narrative review. Clinical and Translational Science. https://doi.org/10.1111/cts.13569

Vancouver

Mohseni Afshar Z, Tavakoli Pirzaman A, Hosseinzadeh R, Babazadeh A, Taghizadeh Moghadam MA, Miri SR, et al. Anticoagulant therapy in COVID ‐19: A narrative review. Clinical and Translational Science. 2023. doi:10.1111/cts.13569

BibTeX
@article{MohseniAfshar2023,
  author = {Mohseni Afshar, Zeinab and Tavakoli Pirzaman, Ali and Hosseinzadeh, Rezvan and Babazadeh, Arefeh and Taghizadeh Moghadam, Mohamad Ali and Miri, Seyed Rouhollah and Sio, Terence T and Sullman, Mark J M and Barary, Mohammad and Ebrahimpour, Soheil},
  title = {Anticoagulant therapy in COVID ‐19: A narrative review},
  journal = {Clinical and Translational Science},
  year = {2023},
  doi = {10.1111/cts.13569}
}
Kostenlos starten →